Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Pycnogenol, a standardized extract from the bark of the French maritime pine (Pinus pinaster), has some scientific evidence supporting its use in managing edema, particularly chronic venous insufficiency (CVI)-related edema. Several randomized controlled trials have investigated its efficacy. These studies suggest that Pycnogenol may help reduce leg swelling, improve microcirculation, and alleviate symptoms such as heaviness and pain associated with venous edema. The proposed mechanisms include antioxidative, anti-inflammatory, and endothelial-protective effects, which may stabilize capillary walls and decrease capillary permeability, thus reducing fluid leakage into tissues.

A notable study published in Angiology (2000) found that subjects with CVI who took Pycnogenol experienced significant reductions in lower leg edema compared to placebo. Other trials have replicated similar findings, though most studies are relatively small and sometimes industry-sponsored, raising concerns about potential bias. Meta-analyses point to moderate efficacy, but also highlight the need for larger, independent studies to confirm these benefits and determine optimal dosing and long-term safety.

Overall, the current body of evidence suggests Pycnogenol may be beneficial for edema related to venous insufficiency, but it should not replace standard medical treatments without consulting a healthcare provider. Its use for edema from other causes (such as heart, kidney, or liver disease) is not well supported.

More about Pycnogenol
More about Edema

Other ingredients used for Edema

Other health conditions supported by Pycnogenol

Products containing Pycnogenol